Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer

Fig. 6

Clinical significance of ZBTB4 expression in pancreatic ductal adenocarcinoma. A ZBTB4 mRNA levels in peripheral blood of healthy individuals and pancreatic cancer patients in GSE125158. B Diagnostic ROC curve model drawn from GSE125158. Area under curve(AUC);True positive rate(TPR); False positive rate(FPR); Confidence interval(CI). C Pairwise analysis of ZBTB4 protein immunohistochemical staining scores. D Expression of ZBTB4 in pancreatic cancer tissue sections. E Correlation analysis of ZBTB4 expression with clinical characteristics of patients. ns = p > 0.05, *p < 0.05, ** p < 0.01, ***p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us